Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP861936.RA3zyR1MWktoYGmBxrf3XV-PL1DlpN-SdLLcwD7FfY9ew130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP861936.RA3zyR1MWktoYGmBxrf3XV-PL1DlpN-SdLLcwD7FfY9ew130_assertion type Assertion NP861936.RA3zyR1MWktoYGmBxrf3XV-PL1DlpN-SdLLcwD7FfY9ew130_head.
- NP861936.RA3zyR1MWktoYGmBxrf3XV-PL1DlpN-SdLLcwD7FfY9ew130_assertion description "[RASSF1A promoter hypermethylation was detected in 100% of SCLC, in 63% of NSCLC, in 64% of breast cancer lines, in 30% of primary NSCLCs, and in 49% of primary breast tumors but in none of the nonmalignant lung tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861936.RA3zyR1MWktoYGmBxrf3XV-PL1DlpN-SdLLcwD7FfY9ew130_provenance.
- NP861936.RA3zyR1MWktoYGmBxrf3XV-PL1DlpN-SdLLcwD7FfY9ew130_assertion evidence source_evidence_literature NP861936.RA3zyR1MWktoYGmBxrf3XV-PL1DlpN-SdLLcwD7FfY9ew130_provenance.
- NP861936.RA3zyR1MWktoYGmBxrf3XV-PL1DlpN-SdLLcwD7FfY9ew130_assertion SIO_000772 11333291 NP861936.RA3zyR1MWktoYGmBxrf3XV-PL1DlpN-SdLLcwD7FfY9ew130_provenance.
- NP861936.RA3zyR1MWktoYGmBxrf3XV-PL1DlpN-SdLLcwD7FfY9ew130_assertion wasDerivedFrom befree-20150227 NP861936.RA3zyR1MWktoYGmBxrf3XV-PL1DlpN-SdLLcwD7FfY9ew130_provenance.
- NP861936.RA3zyR1MWktoYGmBxrf3XV-PL1DlpN-SdLLcwD7FfY9ew130_assertion wasGeneratedBy ECO_0000203 NP861936.RA3zyR1MWktoYGmBxrf3XV-PL1DlpN-SdLLcwD7FfY9ew130_provenance.